LFSTHIGH SIGNALFINANCIAL10-K

LFST achieved a dramatic turnaround from -$57.4M net loss to $9.7M profit while significantly expanding operations and strengthening its balance sheet.

This represents a fundamental transformation in LFST's financial performance, moving from unprofitable to profitable while simultaneously growing revenue 13.9% and expanding clinician headcount by 8.3%. The combination of operational leverage and improved profitability suggests the company has reached an inflection point in its business model maturation.

Comparing 2026-02-25 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

LFST delivered exceptional financial improvement with operating income swinging from -$31.6M loss to $24.1M profit and net income turning positive at $9.7M versus prior year's -$57.4M loss, while revenue grew a solid 13.9% to $1.4B. The company strengthened its balance sheet significantly with cash increasing 60.9% to $248.6M and accounts receivable declining 27.4%, indicating improved collections efficiency, though current liabilities rose modestly 10.1%. The 67.5% increase in capital expenditures to $36.1M signals aggressive growth investment, supported by strong 36.3% operating cash flow growth to $146.2M, positioning the company well for continued expansion.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+176.4%
-$31.6M$24.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+116.8%
-$57.4M$9.7M

Net income grew 116.8% — bottom-line growth signals improving overall business health.

Capital Expenditure
Cash Flow
+67.5%
$21.6M$36.1M

Capital expenditure jumped 67.5% — major investment cycle underway; assess returns on deployment.

Cash & Equivalents
Balance Sheet
+60.9%
$154.6M$248.6M

Cash position surged 60.9% — strong cash generation or capital raise providing significant financial cushion.

Interest Expense
P&L
-56.1%
$26.5M$11.7M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
+36.3%
$107.3M$146.2M

Operating cash flow surged 36.3% — exceptional cash generation, highest quality earnings signal.

Current Assets
Balance Sheet
+33.2%
$312.5M$416.2M

Current assets grew 33.2% — improving short-term liquidity or inventory/receivables build.

Accounts Receivable
Balance Sheet
-27.4%
$131.8M$95.7M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Revenue
P&L
+13.9%
$1.3B$1.4B

Revenue growing 13.9% — solid top-line momentum, watch margins for quality of growth.

Current Liabilities
Balance Sheet
+10.1%
$228.9M$252.0M

Current liabilities rose 10.1% — increased short-term obligations, watch current ratio.

LANGUAGE CHANGES
NEW — 2026-02-25
PRIOR — 2025-02-27
ADDED
We employed 8,040 licensed mental health clinicians through our subsidiaries and supported practices in 33 states as of December 31, 2025.
In a 2022 study of patients with serious mental illness not receiving care in the prior year, 29% reported that they did not know where to go for services, suggesting issues related to access.
For the year ended December 31, 2025, 90% of our revenue was derived from patients with commercial in-network payors, 5% of our revenue was derived from patients with government payors, 4% of our revenue was derived from patients on a self-pay basis and 1% of our revenue was derived from non-patient services.
2 Our Patients Gain Access to High-Quality Care When and Where They Need It Our clinicians treated more than 1.0 million unique patients through approximately 9.0 million visits in 2025.
We believe our superior patient experience drives increased patient engagement in 2025, 87% of our patients had two or more visits with our clinicians.
+7 more — sign up free →
REMOVED
We employed 7,424 licensed mental health clinicians through our subsidiaries and supported practices in 33 states as of December 31, 2024.
Of patients with serious mental illness not receiving care in the past year, 29% reported that they did not know where to go for services, suggesting issues related to access.
For the year ended December 31, 2024, 91% of our revenue was derived from patients with commercial in-network payors, 5% of our revenue was derived from patients with government payors, 3% of our revenue was derived from patients on a self-pay basis and 1% of our revenue was derived from non-patient services.
2 Our Patients Gain Access to High-Quality Care When and Where They Need It Our clinicians treated more than 940,000 unique patients through approximately 7.9 million visits in 2024.
We believe our superior patient experience drives increased patient engagement in 2024, 86% of our patients have had two or more visits with our clinicians.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →